NDC properties for "dabigatran etexilate 75 MG (as dabigatran etexilate mesylate 86.48 MG) Oral Capsule" (RxCUI 1037179)
About this data
The tables show NDC propoerties for dabigatran etexilate 75 MG (as dabigatran etexilate mesylate 86.48 MG) Oral Capsule with the RxCUI 1037179
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for dabigatran etexilate 75 MG (as dabigatran etexilate mesylate 86.48 MG) Oral Capsule (RxCUI 1037179)
| ANDA | ANDA207961 |
|---|---|
| ANDA | ANDA208040 |
| ANDA | ANDA208048 |
| ANDA | ANDA208067 |
| ANDA | ANDA208070 |
| ANDA | ANDA213879 |
| ANDA | ANDA215233 |
| MMSL_CODE | BD23545 |
| MMSL_CODE | CD23545 |
| RxCUI | 1037179 |
| SNOMEDCT | 840698008 |
| SPL_SET_ID | 13649035-a498-4e31-a7ea-8b18cedceca7 |
| SPL_SET_ID | 19b3bfc1-4fcb-4eb9-a611-02c27c05c56e |
| SPL_SET_ID | 27e95caf-7938-ef8e-e063-6394a90a6a1a |
| SPL_SET_ID | 3a8ec82a-c367-40dc-9302-e1896fcb05ea |
| SPL_SET_ID | 3c24e235-218b-438e-9456-42c18ff01913 |
| SPL_SET_ID | 51e81a59-9fc8-4a78-a349-068213dfda9d |
| SPL_SET_ID | 6f79088b-b353-485a-9df4-6f5088f5bd0f |
| SPL_SET_ID | 834a3c5f-b723-4bcb-a560-dc305dd0d829 |
| SPL_SET_ID | a608e019-db9a-d6fb-cd0d-cecc1351a2b1 |
| SPL_SET_ID | baafb5be-ffe6-4755-a7ab-817b3c9b222d |
| SPL_SET_ID | bee57f1b-ee5f-4f81-ae6f-ea65ddf9a174 |
| SPL_SET_ID | dd47a015-ff90-d7a7-8dcb-4e6e31a68071 |
| VUID | 4030250 |
| VUID | 4030251 |
| Prescribable Synonym | dabigatran etexilate 75 MG Oral Capsule |
| RXNAV_STR | dabigatran etexilate 75 MG Oral Capsule |
| RxNorm Name | dabigatran etexilate 75 MG Oral Capsule |
| RxNorm Synonym | dabigatran etexilate 75 MG (as dabigatran etexilate mesylate 86.48 MG) Oral Capsule |
| Related queries | Interactions (for RxCUI 1037179) |
NDC Properties
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |
NDC Item 00378026591
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-91 |
| NDC Item | 00378026591 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0265-91) |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 00378026593
| NDC 9 | 0378-0265 |
|---|---|
| NDC 10 | 0378-0265-93 |
| NDC Item | 00378026593 |
| Packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;75 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-0265 |
NDC Item 31722062131
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-31 |
| NDC Item | 31722062131 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062132
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-32 |
| NDC Item | 31722062132 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 31722062160
| NDC 9 | 31722-621 |
|---|---|
| NDC 10 | 31722-621-60 |
| NDC Item | 31722062160 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-621-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D10 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-621 |
NDC Item 42291003360
| NDC 9 | 42291-033 |
|---|---|
| NDC 10 | 42291-033-60 |
| NDC Item | 42291003360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (42291-033-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;75 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 42291-033 |
NDC Item 43598064260
| NDC 9 | 43598-642 |
|---|---|
| NDC 10 | 43598-642-60 |
| NDC Item | 43598064260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 75 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-642 |
NDC Item 46708063406
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-06 |
| NDC Item | 46708063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 46708063460
| NDC 9 | 46708-634 |
|---|---|
| NDC 10 | 46708-634-60 |
| NDC Item | 46708063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 46708-634 |
NDC Item 50090753100
| NDC 9 | 50090-7531 |
|---|---|
| NDC 10 | 50090-7531-0 |
| NDC Item | 50090753100 |
| Packaging | 60 CAPSULE in 1 BOTTLE (50090-7531-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870665 |
| Imprint code | MD;75 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 50090-7531 |
NDC Item 60505434706
| NDC 9 | 60505-4347 |
|---|---|
| NDC 10 | 60505-4347-6 |
| NDC Item | 60505434706 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4347-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D75 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4347 |
NDC Item 60687074411
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-11 |
| NDC Item | 60687074411 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 60687074421
| NDC 9 | 60687-744 |
|---|---|
| NDC 10 | 60687-744-21 |
| NDC Item | 60687074421 |
| Packaging | 30 BLISTER PACK in 1 CARTON (60687-744-21) / 1 CAPSULE in 1 BLISTER PACK (60687-744-11) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D10 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60687-744 |
NDC Item 62332063406
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-06 |
| NDC Item | 62332063406 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-634-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 62332063460
| NDC 9 | 62332-634 |
|---|---|
| NDC 10 | 62332-634-60 |
| NDC Item | 62332063460 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-634-60) |
| ANDA | ANDA215233 |
| COLORTEXT | WHITE(White opaque) |
| Color | C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;329 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 62332-634 |
NDC Item 67877047460
| NDC 9 | 67877-474 |
|---|---|
| NDC 10 | 67877-474-60 |
| NDC Item | 67877047460 |
| Packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| ANDA | ANDA208040 |
| COLORTEXT | WHITE(Light cream opaque) |
| Color | C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;75 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-474 |
NDC Item 72205020234
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-34 |
| NDC Item | 72205020234 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-202-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72205020260
| NDC 9 | 72205-202 |
|---|---|
| NDC 10 | 72205-202-60 |
| NDC Item | 72205020260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-202-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;75 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72205-202 |
NDC Item 72865027260
| NDC 9 | 72865-272 |
|---|---|
| NDC 10 | 72865-272-60 |
| NDC Item | 72865027260 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72865-272-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D10 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 72865-272 |